PT - JOURNAL ARTICLE AU - Chorin, Ehud AU - Dai, Matthew AU - Shulman, Eric AU - Wadhwani, Lalit AU - Roi-Bar-Cohen, AU - Barbhaiya, Chirag AU - Aizer, Anthony AU - Holmes, Douglas AU - Bernstein, Scott AU - Spinelli, Michael AU - Park, David S. AU - Chinitz, Larry A. AU - Jankelson, Lior TI - The QT Interval in Patients with SARS-CoV-2 Infection Treated with Hydroxychloroquine/Azithromycin AID - 10.1101/2020.04.02.20047050 DP - 2020 Jan 01 TA - medRxiv PG - 2020.04.02.20047050 4099 - http://medrxiv.org/content/early/2020/04/03/2020.04.02.20047050.short 4100 - http://medrxiv.org/content/early/2020/04/03/2020.04.02.20047050.full AB - We report the change in the QT interval in 84 adult patients with SARS-CoV-2 infection treated with Hydroxychloroquine/Azithromycin combination. QTc prolonged maximally from baseline between days 3 and 4. in 30% of patients QTc increased by greater than 40ms. In 11% of patients QTc increased to >500 ms, representing high risk group for arrhythmia. The development of acute renal failure but not baseline QTc was a strong predictor of extreme QTc prolongation.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding providedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesWe will make data available after approval of data committee